Concepedia

Thomas Grote

TG

35

Publications

2.1K

Citations

21

H-Index

1987

Active since

Affiliations

University of Tübingen(Current)

Ethics and Public Policy Center

Bernstein Center for Computational Neuroscience Tübingen

Vanderbilt University

University of Göttingen

Thomas Grote is an author at University of Tübingen specializing in medicine, pharmacology, and pharmacotherapy.

Top concepts

MedicinePharmacologyPharmacotherapyArtificial IntelligenceOncologyHealth InformaticsEngineeringDrug DiscoveryHealthClinical Trials

Publications per year

1987–2024

35

Publications

35

On the ethics of algorithmic decision-making in healthcare

Thomas Grote, Philipp Berens · Journal of Medical Ethics · 2019 · 489 citations · Full text

Artificial Intelligence, Engineering, Machine Learning +19

Reduction of Cisplatin-Induced Emesis by a Selective Neurokinin-1–Receptor Antagonist

Rudolph M. Navari, Rick R. Reinhardt, Richard J. Gralla et al. · New England Journal of Medicine · 1999 · 370 citations · Full text

Double-blind, randomized comparison of the antiemetic efficacy of intravenous dolasetron mesylate and intravenous ondansetron in the prevention of acute cisplatin-induced emesis in patients with cancer. Dolasetron Comparative Chemotherapy-induced Emesis Prevention Group.

Paul J. Hesketh, Rudolph M. Navari, Thomas Grote et al. · Journal of Clinical Oncology · 1996 · 148 citations

Atypical Carcinoid of the Lung

Thomas Grote, William R. Macon, Ben Davis et al. · CHEST Journal · 1988 · 95 citations

Medicine, Multiple Pulmonary Nodule, Pathology +6

Combination therapy for chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy: palonosetron, dexamethasone, and aprepitant.

Thomas Grote, Julio Hajdenberg, Alan Cartmell et al. · PubMed · 2006 · 91 citations

Emetogenic Chemotherapy, Receptor Antagonist, Pharmacotherapy +16

Rows per page

1–5 of 35